Attendee search 

Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, OTC and biosimilar products around the world.

A unique portfolio of high-quality and difficult-to-make products fuels our targeted growth strategy.

The company has commercial operations in 35 countries with 2,800 employees and operates five manufacturing and development hubs in the U.S., Romania, Korea and Taiwan.

Alvogen's product portfolio consists of a broad range of leading molecules for the treatment of conditions in the areas of oncology, cardiology, respiratory, Women Health, neurology and gastroenterology, in addition to a fast-growing portfolio of biosimilars and OTC products.  

Indena is the leading company dedicated to the identification, development and production of high quality active principles derived from plants, for use in the pharmaceutical, health-food and personal care industries, complying with the most strict regulations. Backed up by over 90 years of botanical experience, the company has more than 120 primary patents, has published more than 700 scientific studies and co-operates with the world’s most prestigious universities and private research institutions. Headquartered in Milan, Indena has 5 production sites and 5 international branches throughout the world and manages sales in more than 70 countries.


In the supplements’ field, Indena has developed a collection of products, containing clinically validated botanical actives for a variety of health needs, ranging from the CV to the joint health field, from metabolism to the gut health sector. These ready-to-market final formulations have been designed and developed to maximize the performance of the active ingredients and to guarantee their quality and stability over time. All proposed formulations can be tailored to fulfill specific regulatory or customer requirements.